This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: Thermo Fisher-Olink deal raises questions over competition vs. efficiencies in fast-evolving market

By Jon Menon and Nicholas Hirst ( April 19, 2024, 13:31 GMT | Comment) -- Thermo Fisher Scientific’s planned Olink acquisition may make regulators weigh concerns that innovation could be harmed, against potential efficiencies in the fast-growing market for testing proteins. The US health giant’s proposed $3.1 billion buyout of a smaller Swedish rival currently awaits an initial review by the UK merger regulator and is under an in-depth probe in Germany.Thermo Fisher Scientific’s proposal to acquire Olink may require UK and German regulators to consider the deal's potential impact on innovation versus potential efficiency gains in the rapidly expanding protein-testing market....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login